Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.3466
S.3466: Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2020
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced March 12, 2020
- Latest Major Action March 12, 2020
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in Senate - March 12, 2020
Bill Summary
Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2020 or the ACCESS for Biosimilars Act of 2020 This bill temporarily eliminates cost-sharing for biosimilar biological products for certain qualifying beneficiaries under Medicare medical services. Specifically, the bill eliminates cost-sharing for beneficiaries whose coverage under private health insurance, a federal program (other than Medicare), a Medicare...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
| Date | Description |
|---|---|
| March 12, 2020 |
Read twice and referred to the Committee on Finance.
|
| March 12, 2020 |
Introduced in the Senate by Martha McSally (R-Ariz.) |